Agios Pharmaceuticals | AGIO - Les Intérêts Débiteurs Sur La Dette





Les Intérêts Débiteurs Sur La Dette Changement Date
AbbVie USD 746M 101M 2026-06
Agios Pharmaceuticals USD 1.11B 76.57M 2026-06
Alnylam Pharmaceuticals USD -84.37M 166.42M 2026-09
Amgen USD 95.64B 94.98B 2026-06
Arrowhead Research USD 24.56M 716K 2026-06
Astellas Pharma JPY 3.91B 320M 2025-03
AstraZeneca USD 371M 31M 2026-09
Bayer EUR 675M 87M 2025-12
Biogen USD 72.6M 12.6M 2025-06
BioMarin Pharmaceutical USD 63.29M 48.34M 2026-06
Bristol-Myers Squibb USD 403M 4M 2026-09
Daiichi Sankyo JPY 14.13B 10.56B 2026-09
Eli Lilly USD 316M 201.3M 2026-09
Exelixis USD 23.4M 3.9M 2023-09
Gilead Sciences USD 269M 22M 2026-09
GlaxoSmithKline GBP 219M 98M 2026-09
Incyte USD 605K 23K 2026-09
Ionis Pharmaceuticals USD 18M 1000K 2026-06
Merck USD 525M 46M 2026-06
Moderna USD 10.96B 527M 2026-06
Nektar Therapeutics USD 7.94M 1.83M 2026-03
Novartis USD 462M 119M 2026-06
Novartis USD 281M 8M 2025-09
Pfizer USD 667M 4M 2026-06
Puma Biotechnology USD 3.37M 11K 2024-06
Regeneron Pharmaceuticals USD 11M 1.9M 2026-06
Roche Holding CHF 304M 7.5M 2025-06
Sarepta Therapeutics USD 21.51M 205K 2026-06
Vertex Pharmaceuticals USD 3.3M 0 2025-12